Xyrem regulatory update

FDA approved an ANDA from the West-Ward Pharmaceuticals Corp. subsidiary of Hikma Pharmaceuticals plc (LSE:HIK, London, U.K.) for a generic version of Xyrem sodium oxybate to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy. West-Ward declined to disclose a timeline for launching the generic. Xyrem is an oral liquid formulation of the sodium salt of gamma hydroxybutyrate (GHB)...